ABIVAX Société Anonyme
AAVXF
$6.91
$1.0217.32%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 3.65M | 3.68M | 1.21M | 1.22M | 1.22M |
| Total Revenue | 3.65M | 3.68M | 1.21M | 1.22M | 1.22M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 3.65M | 3.68M | 1.21M | 1.22M | 1.22M |
| SG&A Expenses | 11.93M | 12.03M | 11.79M | 11.92M | 3.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -15.60K | -15.70K | -21.50K | -21.80K | -3.80K |
| Total Operating Expenses | 46.70M | 47.10M | 49.75M | 50.30M | 21.51M |
| Operating Income | -43.05M | -43.42M | -48.54M | -49.08M | -20.29M |
| Income Before Tax | -43.93M | -44.31M | -51.56M | -52.13M | -28.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.93M | -44.31M | -51.56M | -52.13M | -28.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -43.93M | -44.31M | -51.56M | -52.13M | -28.28M |
| EBIT | -43.05M | -43.42M | -48.54M | -49.08M | -20.29M |
| EBITDA | -42.96M | -43.33M | -48.47M | -49.00M | -20.25M |
| EPS Basic | -0.70 | -0.70 | -1.03 | -1.04 | -0.79 |
| Normalized Basic EPS | -0.44 | -0.44 | -0.66 | -0.67 | -0.49 |
| EPS Diluted | -0.70 | -0.70 | -1.03 | -1.04 | -0.79 |
| Normalized Diluted EPS | -0.44 | -0.44 | -0.66 | -0.67 | -0.49 |
| Average Basic Shares Outstanding | 62.92M | 62.92M | 50.23M | 50.23M | 35.90M |
| Average Diluted Shares Outstanding | 62.92M | 62.92M | 50.23M | 50.23M | 35.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
